275 related articles for article (PubMed ID: 20458159)
1. Production of specific antibodies against SARS-coronavirus nucleocapsid protein without cross reactivity with human coronaviruses 229E and OC43.
Lee HK; Lee BH; Seok SH; Baek MW; Lee HY; Kim DJ; Na YR; Noh KJ; Park SH; Kumar DN; Kariwa H; Nakauchi M; Heo SJ; Park JH
J Vet Sci; 2010 Jun; 11(2):165-7. PubMed ID: 20458159
[TBL] [Abstract][Full Text] [Related]
2. [Antigenicity analysis of nucleocapsid proteins of 3 human coronaviruses SARS-CoV, 229E and OC43 with their monoclonal antibodies].
Qiu LW; Wang YD; Liao ZY; Wen K; Che XY
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Mar; 26(3):290-3. PubMed ID: 16546729
[TBL] [Abstract][Full Text] [Related]
3. False-positive results in a recombinant severe acute respiratory syndrome-associated coronavirus (SARS-CoV) nucleocapsid enzyme-linked immunosorbent assay due to HCoV-OC43 and HCoV-229E rectified by Western blotting with recombinant SARS-CoV spike polypeptide.
Woo PC; Lau SK; Wong BH; Chan KH; Hui WT; Kwan GS; Peiris JS; Couch RB; Yuen KY
J Clin Microbiol; 2004 Dec; 42(12):5885-8. PubMed ID: 15583332
[TBL] [Abstract][Full Text] [Related]
4. Antigenic cross-reactivity between severe acute respiratory syndrome-associated coronavirus and human coronaviruses 229E and OC43.
Che XY; Qiu LW; Liao ZY; Wang YD; Wen K; Pan YX; Hao W; Mei YB; Cheng VC; Yuen KY
J Infect Dis; 2005 Jun; 191(12):2033-7. PubMed ID: 15897988
[TBL] [Abstract][Full Text] [Related]
5. Serological responses in patients with severe acute respiratory syndrome coronavirus infection and cross-reactivity with human coronaviruses 229E, OC43, and NL63.
Chan KH; Cheng VC; Woo PC; Lau SK; Poon LL; Guan Y; Seto WH; Yuen KY; Peiris JS
Clin Diagn Lab Immunol; 2005 Nov; 12(11):1317-21. PubMed ID: 16275947
[TBL] [Abstract][Full Text] [Related]
6. Immunoreactivity characterisation of the three structural regions of the human coronavirus OC43 nucleocapsid protein by Western blot: implications for the diagnosis of coronavirus infection.
Liang FY; Lin LC; Ying TH; Yao CW; Tang TK; Chen YW; Hou MH
J Virol Methods; 2013 Feb; 187(2):413-20. PubMed ID: 23174159
[TBL] [Abstract][Full Text] [Related]
7. Characterization and epitope mapping of monoclonal antibodies to the nucleocapsid protein of severe acute respiratory syndrome coronavirus.
Kariwa H; Noda H; Nakauchi M; Ishizuka M; Hashiguchi K; Hashimoto S; Yoshii K; Asano A; Agui T; Kogaki H; Kurano Y; Uchida Y; Fujii N; Okada M; Takashima I
Jpn J Vet Res; 2008 Feb; 55(4):115-27. PubMed ID: 18380153
[TBL] [Abstract][Full Text] [Related]
8. Antigenic cross-reactivity between the nucleocapsid protein of severe acute respiratory syndrome (SARS) coronavirus and polyclonal antisera of antigenic group I animal coronaviruses: implication for SARS diagnosis.
Sun ZF; Meng XJ
J Clin Microbiol; 2004 May; 42(5):2351-2. PubMed ID: 15131233
[No Abstract] [Full Text] [Related]
9. Antibody Mediated Immunity to SARS-CoV-2 and Human Coronaviruses: Multiplex Beads Assay and Volumetric Absorptive Microsampling to Generate Immune Repertoire Cartography.
Wang J; Li D; Zhou Q; Wiltse A; Zand MS
Front Immunol; 2021; 12():696370. PubMed ID: 34386006
[TBL] [Abstract][Full Text] [Related]
10. Healthy donor T cell responses to common cold coronaviruses and SARS-CoV-2.
Woldemeskel BA; Kwaa AK; Garliss CC; Laeyendecker O; Ray SC; Blankson JN
J Clin Invest; 2020 Dec; 130(12):6631-6638. PubMed ID: 32966269
[TBL] [Abstract][Full Text] [Related]
11. Seroprevalence and SARS-CoV-2 cross-reactivity of endemic coronavirus OC43 and 229E antibodies in Finnish children and adults.
Tamminen K; Salminen M; Blazevic V
Clin Immunol; 2021 Aug; 229():108782. PubMed ID: 34118402
[TBL] [Abstract][Full Text] [Related]
12. Two-way antigenic cross-reactivity between severe acute respiratory syndrome coronavirus (SARS-CoV) and group 1 animal CoVs is mediated through an antigenic site in the N-terminal region of the SARS-CoV nucleoprotein.
Vlasova AN; Zhang X; Hasoksuz M; Nagesha HS; Haynes LM; Fang Y; Lu S; Saif LJ
J Virol; 2007 Dec; 81(24):13365-77. PubMed ID: 17913799
[TBL] [Abstract][Full Text] [Related]
13. Biochemical and immunological studies of nucleocapsid proteins of severe acute respiratory syndrome and 229E human coronaviruses.
Tang TK; Wu MP; Chen ST; Hou MH; Hong MH; Pan FM; Yu HM; Chen JH; Yao CW; Wang AH
Proteomics; 2005 Mar; 5(4):925-37. PubMed ID: 15759315
[TBL] [Abstract][Full Text] [Related]
14. Coronavirus Pseudotypes for All Circulating Human Coronaviruses for Quantification of Cross-Neutralizing Antibody Responses.
Sampson AT; Heeney J; Cantoni D; Ferrari M; Sans MS; George C; Di Genova C; Mayora Neto M; Einhauser S; Asbach B; Wagner R; Baxendale H; Temperton N; Carnell G
Viruses; 2021 Aug; 13(8):. PubMed ID: 34452443
[TBL] [Abstract][Full Text] [Related]
15. The expression and antigenicity of a truncated spike-nucleocapsid fusion protein of severe acute respiratory syndrome-associated coronavirus.
Mu F; Niu D; Mu J; He B; Han W; Fan B; Huang S; Qiu Y; You B; Chen W
BMC Microbiol; 2008 Nov; 8():207. PubMed ID: 19038059
[TBL] [Abstract][Full Text] [Related]
16. Development of a recombinant truncated nucleocapsid protein based immunoassay for detection of antibodies against human coronavirus OC43.
Blanchard EG; Miao C; Haupt TE; Anderson LJ; Haynes LM
J Virol Methods; 2011 Oct; 177(1):100-6. PubMed ID: 21801752
[TBL] [Abstract][Full Text] [Related]
17. Peptide microarray-based analysis of antibody responses to SARS-CoV-2 identifies unique epitopes with potential for diagnostic test development.
Holenya P; Lange PJ; Reimer U; Woltersdorf W; Panterodt T; Glas M; Wasner M; Eckey M; Drosch M; Hollidt JM; Naumann M; Kern F; Wenschuh H; Lange R; Schnatbaum K; Bier FF
Eur J Immunol; 2021 Jul; 51(7):1839-1849. PubMed ID: 33772767
[TBL] [Abstract][Full Text] [Related]
18. Mapping SARS-CoV-2 Antibody Epitopes in COVID-19 Patients with a Multi-Coronavirus Protein Microarray.
Camerini D; Randall AZ; Trappl-Kimmons K; Oberai A; Hung C; Edgar J; Shandling A; Huynh V; Teng AA; Hermanson G; Pablo JV; Stumpf MM; Lester SN; Harcourt J; Tamin A; Rasheed M; Thornburg NJ; Satheshkumar PS; Liang X; Kennedy RB; Yee A; Townsend M; Campo JJ
Microbiol Spectr; 2021 Oct; 9(2):e0141621. PubMed ID: 34704808
[TBL] [Abstract][Full Text] [Related]
19. False-positive results in a recombinant severe acute respiratory syndrome-associated coronavirus (SARS-CoV) nucleocapsid-based western blot assay were rectified by the use of two subunits (S1 and S2) of spike for detection of antibody to SARS-CoV.
Maache M; Komurian-Pradel F; Rajoharison A; Perret M; Berland JL; Pouzol S; Bagnaud A; Duverger B; Xu J; Osuna A; Paranhos-Baccalà G
Clin Vaccine Immunol; 2006 Mar; 13(3):409-14. PubMed ID: 16522785
[TBL] [Abstract][Full Text] [Related]
20. Differentiation between human coronaviruses NL63 and 229E using a novel double-antibody sandwich enzyme-linked immunosorbent assay based on specific monoclonal antibodies.
Sastre P; Dijkman R; Camuñas A; Ruiz T; Jebbink MF; van der Hoek L; Vela C; Rueda P
Clin Vaccine Immunol; 2011 Jan; 18(1):113-8. PubMed ID: 21084464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
